{"id":32,"date":"2023-05-25T22:43:28","date_gmt":"2023-05-26T02:43:28","guid":{"rendered":"https:\/\/nanobiotix.com\/?page_id=32"},"modified":"2025-06-06T13:35:22","modified_gmt":"2025-06-06T17:35:22","slug":"partners","status":"publish","type":"page","link":"https:\/\/nanobiotix.com\/fr\/partners\/","title":{"rendered":"Partenaires"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Partenariats & collaborations<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Collaborations\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Ancr\u00e9e en France, pr\u00e9sente dans le monde entier<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Chez Nanobiotix, nous travaillons en collaboration avec des partenaires de renomm\u00e9e mondiale afin de poursuivre le d\u00e9veloppement de nanoth\u00e9rapies au potentiel r\u00e9volutionnaire, fond\u00e9es sur la physique. Aujourd\u2019hui, nous nous concentrons sur la cr\u00e9ation de partenariats avec des entreprises cherchant \u00e0 mettre \u00e0 profit notre plateforme de nanoprimer Curadigm pour lever les contraintes que constituent la clairance rapide de la circulation sanguine, la faible biodisponibilit\u00e9 qui en r\u00e9sulte, la faible accumulation dans les tissus cibles et\/ou l\u2019h\u00e9patotoxicit\u00e9 de leurs candidats th\u00e9rapeutiques.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

En savoir plus sur notre plateforme de nanoprimer Curadigm <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tD\u00e9couvrir Curadigm <\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tirer parti de notre approche scientifique r\u00e9volutionnaire<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tDevenir un partenaire <\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Collaborations NBTXR3<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

D\u00e9couvrir notre plateforme de nanoradioenhancers<\/strong><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Janssen\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Janssen, une entit\u00e9 du groupe Janssen Pharmaceutical Companies of Johnson & Johnson, cr\u00e9e un avenir o\u00f9 la maladie appartient au pass\u00e9, travaillant sans rel\u00e2che pour faire de cet avenir une r\u00e9alit\u00e9 pour les patients du monde entier en combattant la maladie par la science, en am\u00e9liorant l'acc\u00e8s par l'ing\u00e9niosit\u00e9, et en gu\u00e9rissant le d\u00e9sespoir par le c\u0153ur. Nanobiotix s'associe \u00e0 Janssen pour le cod\u00e9veloppement et la commercialisation \u00e0 l'\u00e9chelle mondiale de NBTXR3.<\/p>

Pour en savoir plus, rendez-vous sur janssen.com<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Le MD Anderson Cancer Center de l'Universit\u00e9 du Texas a pour mission d'\u00e9liminer le cancer au Texas, aux \u00c9tats-Unis et dans le monde gr\u00e2ce \u00e0 des programmes exceptionnels qui int\u00e8grent les soins aux patients, la recherche et la pr\u00e9vention, et l'\u00e9ducation des \u00e9tudiants de premier et deuxi\u00e8me cycles, des stagiaires, des professionnels, des employ\u00e9s et du public. Nanobiotix collabore avec le MD Anderson pour \u00e9tendre le d\u00e9veloppement de NBTXR3 \u00e0 diff\u00e9rentes tumeurs solides et en combinaison avec diff\u00e9rents agents anti-canc\u00e9reux, parall\u00e8lement aux \u00e9tudes men\u00e9es par l'entreprise.<\/p>\n

Pour en savoir plus, rendez-vous sur mdanderson.org<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Collaborations Curadigm<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

D\u00e9couvrir notre plateforme de nanoprimers Curadigm<\/strong><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"Sanofi\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"NCL\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"antapodia\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"MIT\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Construire pour le succ\u00e8s \u00e0 long terme<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Nous avons la conviction que NBTXR3 activ\u00e9 par radioth\u00e9rapie pourrait devenir la r\u00e9f\u00e9rence en mati\u00e8re de traitement des cancers. En 2019, NBTXR3 a obtenu l\u2019approbation de son premier marquage \u00ab CE \u00bb pour le traitement du sarcome des tissus mous localement avanc\u00e9 dans 27 pays europ\u00e9ens, sous la marque Hensify\u00ae. NBTXR3 fait actuellement l\u2019objet de 14 essais cliniques dans plusieurs indications diff\u00e9rentes, notamment le cancer de la t\u00eate et du cou, le cancer du poumon non \u00e0 petites cellules et le cancer du pancr\u00e9as.<\/p>

Aujourd\u2019hui, nous consacrons principalement nos ressources \u00e0 la poursuite du d\u00e9veloppement mondial et \u00e0 l\u2019extension dans diff\u00e9rentes indications de NBTXR3. Nos essais cliniques mondiaux et la r\u00e9ussite de l\u2019extension dans diff\u00e9rentes indications d\u00e9montrent le potentiel de NBTXR3 sur tous les march\u00e9s, tandis que nos collaborations actuelles donnent \u00e0 notre produit phare la possibilit\u00e9 de parvenir jusqu'aux patients du monde entier souffrant d\u2019un cancer.<\/p>

NANORAY-312, notre essai clinique de Phase 3 pour le HNSCC, poursuit son d\u00e9veloppement en s\u2019appuyant sur plusieurs sites actifs aux \u00c9tats-Unis, en Europe et en Asie. Nous restons mobilis\u00e9s pour \u00e9tendre le p\u00e9rim\u00e8tre de l\u2019essai, acc\u00e9l\u00e9rer le recrutement des patients et pr\u00e9parer la publication de nos rapports d\u2019\u00e9tape.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

PARTNERS & COLLABORATIONS French foundation, global reach At Nanobiotix, we collaborate with world-class partners to advance our range of disruptive, physics-based nanotherapeutics. At this time, we are focused on partnering with companies interested in leveraging our Curadigm Nanoprimer Platform to overcome the hurdles of rapid clearance, poor bioavailability, low target tissue accumulation, and\/or hepatotoxicity across […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-32","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/nanobiotix.com\/fr\/wp-json\/wp\/v2\/pages\/32","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanobiotix.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nanobiotix.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nanobiotix.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanobiotix.com\/fr\/wp-json\/wp\/v2\/comments?post=32"}],"version-history":[{"count":0,"href":"https:\/\/nanobiotix.com\/fr\/wp-json\/wp\/v2\/pages\/32\/revisions"}],"wp:attachment":[{"href":"https:\/\/nanobiotix.com\/fr\/wp-json\/wp\/v2\/media?parent=32"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}